ANSBERT GADICKE Insider Trading $ITOS iTeos Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ANSBERT GADICKE.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ANSBERT GADICKE. ANSBERT GADICKE is 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in CHIASMA, INC ($CHMA) and Director in Radius Health, Inc. ($RDUS) and 10% Owner in Harpoon Therapeutics, Inc. ($HARP) and Director in Allovir, Inc. ($ALVR) and Director in TCR2 THERAPEUTICS INC. ($TCRR) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in iTeos Therapeutics, Inc. ($ITOS) and Director in iTeos Therapeutics, Inc. ($ITOS) and 10% Owner in Repare Therapeutics Inc. ($RPTX) and Director in Cullinan Management, Inc. ($CGEM).

ANSBERT GADICKE in iTeos Therapeutics, Inc.

Trading Symbol: ITOS
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ANSBERT GADICKE: 10% Owner, Director
Holdings: 6,004,368 shares
Latest Transaction: Apr 13 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of ANSBERT GADICKE in iTeos Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ALVR, CHMA, CGEM, HARP, ITOS, RDUS, RPTX, RIGL, TCRR, HOWL

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 13 2021	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	10% Owner	Sell	S	29.99	200	5,998	6,004,368	6 M to 6 M (0.00 %)
Apr 09 2021	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	10% Owner	Sell	S	31.01	414	12,838	6,004,568	6 M to 6 M (-0.01 %)
Apr 09 2021	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	10% Owner	Sell	S	30.51	31,890	972,964	6,004,982	6 M to 6 M (-0.53 %)
Apr 09 2021	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	10% Owner	Sell	S	31.01	414	12,838	6,004,568	6 M to 6 M (-0.01 %)
Apr 09 2021	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	10% Owner	Sell	J	0.00	15,670	0	6,036,872	6.1 M to 6 M (-0.26 %)
Apr 09 2021	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	10% Owner	Sell	S	30.51	31,890	972,964	6,004,982	6 M to 6 M (-0.53 %)
Apr 09 2021	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	10% Owner	Sell	S	33.84	1,300	43,992	6,052,542	6.1 M to 6.1 M (-0.02 %)
Apr 09 2021	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	10% Owner	Sell	J	0.00	15,670	0	6,036,872	6.1 M to 6 M (-0.26 %)
Apr 09 2021	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	10% Owner	Sell	S	32.84	3,083	101,246	6,053,842	6.1 M to 6.1 M (-0.05 %)
Apr 09 2021	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	10% Owner	Sell	S	33.84	1,300	43,992	6,052,542	6.1 M to 6.1 M (-0.02 %)
Apr 09 2021	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	10% Owner	Sell	S	32.07	5,295	169,811	6,056,925	6.1 M to 6.1 M (-0.09 %)
Apr 09 2021	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	10% Owner	Sell	S	32.84	3,083	101,246	6,053,842	6.1 M to 6.1 M (-0.05 %)
Apr 09 2021	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	10% Owner	Sell	S	32.07	5,295	169,811	6,056,925	6.1 M to 6.1 M (-0.09 %)
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Option Exercise	C	0.00	2,600,628	0	0
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Option Exercise	C	0.00	29,440	0	0
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Option Exercise	C	0.00	79,281	0	0
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Option Exercise	C	0.00	1,491,666	0	0
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Option Exercise	C	0.00	81,295	0	0
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Option Exercise	C	0.00	157,529	0	0
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Option Exercise	C	0.00	2,361,805	0	0
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Option Exercise	C	0.00	4,211,330	0	0
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Option Exercise	C	0.00	47,674	0	0
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Option Exercise	C	0.00	128,384	0	0
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Option Exercise	C	0.00	2,415,530	0	0
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Option Exercise	C	0.00	131,645	0	0
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Option Exercise	C	0.00	255,094	0	0
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Option Exercise	C	0.00	3,824,591	0	0
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	P	19.00	160,000	3,040,000	2,355,557	2.2 M to 2.4 M (+7.29 %)
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	P	19.00	1,121	21,299	25,974	24.9 K to 26 K (+4.51 %)
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	P	19.00	3,020	57,380	69,951	66.9 K to 70 K (+4.51 %)
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	P	19.00	56,814	1,079,466	1,316,139	1.3 M to 1.3 M (+4.51 %)
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	P	19.00	3,096	58,824	71,727	68.6 K to 71.7 K (+4.51 %)
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	P	19.00	5,994	113,886	138,985	133 K to 139 K (+4.51 %)
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	P	19.00	89,955	1,709,145	2,083,887	2 M to 2.1 M (+4.51 %)
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	C	0.00	797,983	0	2,195,557	1.4 M to 2.2 M (+57.10 %)
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	C	0.00	9,033	0	24,853	15.8 K to 24.9 K (+57.10 %)
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	C	0.00	24,326	0	66,931	42.6 K to 66.9 K (+57.10 %)
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	C	0.00	457,706	0	1,259,325	801.6 K to 1.3 M (+57.10 %)
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	C	0.00	24,944	0	68,381	43.4 K to 68.4 K (+57.43 %)
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	C	0.00	48,336	0	132,991	84.7 K to 133 K (+57.10 %)
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	C	0.00	724,702	0	1,993,932	1.3 M to 2 M (+57.10 %)
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	C	0.00	1,397,574	0	1,397,574	0 to 1.4 M
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	C	0.00	15,820	0	15,820	0 to 15.8 K
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	C	0.00	42,605	0	42,605	0 to 42.6 K
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	C	0.00	801,619	0	801,619	0 to 801.6 K
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	C	0.00	43,687	0	43,687	0 to 43.7 K
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	C	0.00	84,655	0	84,655	0 to 84.7 K
Jul 30 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Buy	C	0.00	1,269,230	0	1,269,230	0 to 1.3 M
Jul 24 2020	ITOS	iTeos Therapeutics ...	GADICKE ANSBERT	Director	Option Exercise	A	19.00	16,608	315,552	0

Page: 1